Skip to main content
Signal8

GREGORY JULIA P

SEC insider (Form 3/4/5 filer). CIK 0001226675. Director at Nurix Therapeutics, Inc. (NRIX) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in BRISBANE, CA.

Companies GREGORY JULIA P has filed insider reports for

  • Nurix Therapeutics, Inc. (NRIX): Director
  • Biohaven Ltd. (BHVN): Director
GREGORY JULIA P profile photo

GREGORY JULIA P

CIK: 0001226675

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Nurix Therapeutics, Inc. logo
NRIX

Nurix Therapeutics, Inc.

Director
Biohaven Ltd. logo
BHVN

Biohaven Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Nurix Therapeutics, Inc. logo
    NRIX

    Nurix Therapeutics, Inc.

    Oct 14, 2026
    Exercise
    Direct
    22.6K shares at avg. $1.86$42K
  • Nurix Therapeutics, Inc. logo
    NRIX

    Nurix Therapeutics, Inc.

    Oct 14, 2026
    Sale
    Direct
    22.6K shares at avg. $23.40$529K
  • Nurix Therapeutics, Inc. logo
    NRIX

    Nurix Therapeutics, Inc.

    May 15, 2026
    Award

    Director Stock Option (right to buy)

    Direct
    31.3K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Apr 28, 2026
    Award

    Stock Options (Right to buy)

    Direct
    68.7K shares-
  • Nurix Therapeutics, Inc. logo
    NRIX

    Nurix Therapeutics, Inc.

    Sep 17, 2025
    Exercise
    Direct
    10.8K shares at avg. $1.86$20K
  • Nurix Therapeutics, Inc. logo
    NRIX

    Nurix Therapeutics, Inc.

    May 19, 2025
    Award

    Director Stock Option (right to buy)

    Direct
    25K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    May 5, 2025
    Award

    Stock Options (Right to buy)

    Direct
    31.7K shares-

1-7 of 7